文献速递物质与行为成瘾

美国成人酒精与大麻使用障碍患病率及严重程度趋势

Trends in the Prevalence and Severity of Alcohol and Cannabis Use Disorders Among US Adults.
PubMed 文献 · JAMA Psychiatry · 2026-01-01

IMPORTANCE: The number of US adults with alcohol use disorder (AUD) has declined, whereas the number with cannabis use disorder (CUD) has increased. Little is known about how changes in the prevalence and severity of AUD and CUD vary by age and sex.…

要点

  • 2021至2024年男性大麻使用障碍患病率从7.3%升至9.3%,女性从4.5%升至5.6%。
  • 男性中重度大麻使用障碍从3.1%升至4.1%,女性从1.7%升至2.5%。
  • 中重度酒精使用障碍在男女及多数亚组保持稳定,仅21-34岁男性下降。

核心结论

  • 2021至2024年美国成人中重度大麻使用障碍患病率上升,而中重度酒精使用障碍患病率总体稳定。
  • 大麻使用障碍患病率增加提示需早期识别、常规筛查和及时获得循证治疗。

研究设计与样本

  • 参与者中女性占51.3%,18-20岁占4.9%,21-34岁占24.1%,35-49岁占24.7%。

主要发现

  • 男性大麻使用障碍患病率从7.3%(95%CI 6.6%-8.1%)升至9.3%(95%CI 8.6%-10.1%),P<.001。
  • 女性大麻使用障碍患病率从4.5%(95%CI 4.1%-5.0%)升至5.6%(95%CI 5.2%-6.1%),P=.01。
  • 男性中重度大麻使用障碍从3.1%(95%CI 2.8%-3.6%)升至4.1%(95%CI 3.7%-4.5%),P<.001。
  • 女性中重度大麻使用障碍从1.7%(95%CI 1.5%-2.0%)升至2.5%(95%CI 2.3%-2.8%),P<.001。
  • 女性大麻使用障碍者中中重度比例从37.0%(95%CI 32.5%-41.8%)升至45.0%(95%CI 41.1%-49.0%),P=.03。

关键数值与推荐

  • 采用DSM-5标准评估过去一年酒精使用障碍和大麻使用障碍的患病率及严重程度。

临床怎么用

  • 在临床中应常规筛查大麻使用障碍,尤其关注35-49岁男性、21-34岁及50岁及以上女性。
  • 对使用大麻的成人应评估中重度大麻使用障碍风险,及时提供循证治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The number of US adults with alcohol use disorder (AUD) has declined, whereas the number with cannabis use disorder (CUD) has increased. Little is known about how changes in the prevalence and severity of AUD and CUD vary by age and sex. OBJECTIVE: To investigate trends in AUD and CUD prevalence and severity by age and sex. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study examined data from adult participants in the 2021 to 2024 National Surveys on Drug Use and Health. This study was started and completed in March 2026. EXPOSURE: Alcohol and cannabis use. MAIN OUTCOMES AND MEASURES: Past-year prevalence and severity of AUD and CUD using DSM-5 criteria. RESULTS: From 2021 through 2024 among 186 823 participants (51.3% female; 4.9% aged 18-20 years; 24.1% aged 21-34 years; 24.7% aged 35-49 years), past-year CUD prevalence increased among males (from 7.3% [95% CI, 6.6%-8.1%] to 9.3% [95% CI, 8.6%-10.1%]; P < .001) and females (from 4.5% [95% CI, 4.1%-5.0%] to 5.6% [95% CI, 5.2%-6.1%]; P = .01). Moderate-to-severe CUD prevalence among males increased from 3.1% (95% CI, 2.8%-3.6%) to 4.1% (95% CI, 3.7%-4.5%) (P < .001), especially among males aged 35 to 49 years (from 2.7% [95% CI, 2.0%-3.6%] to 3.9% [95% CI, 3.2%-4.8%]; P = .01) and males aged 50 years or older (from 0.6% [95% CI, 0.3%-1.0%] to 1.2% [95% CI, 0.8%-1.7%]; P = .02). Among females, moderate-to-severe CUD prevalence increased from 1.7% (95% CI, 1.5%-2.0%) to 2.5% (95% CI, 2.3%-2.8%) (P < .001), specifically for females aged 21 to 34 years (from 4.2% [95% CI, 3.5%-5.1%] to 5.6% [95% CI, 4.8%-6.5%]; P = .04), 35 to 49 years (from 1.2% [95% CI, 0.8%-1.8%] to 2.0% [95% CI, 1.6%-2.5%]; P = .01), and 50 years or older (from 0.1% [95% CI, 0.04%-0.3%] to 0.7% [95% CI, 0.5%-1.0%]; P < .001). Among females with CUD, moderate-to-severe CUD prevalence increased from 37.0% (95% CI, 32.5%-41.8%) to 45.0% (95% CI, 41.1%-49.0%) (P = .03). However, moderate-to-severe AUD prevalence remained stable among males overall (except for declines among males aged 21-34 years) and was stable among females overall and within all subgroups. Most males and females aged 18 to 20 years and males aged 21 to 34 years with CUD had moderate-to-severe CUD (eg, 51.0%-61.0% in 2024), with consistent patterns from 2022 through 2024. CONCLUSIONS AND RELEVANCE: This cross-sectional study found divergent age- and sex-specific patterns from 2021 through 2024, with moderate-to-severe CUD prevalence increasing and moderate-to-severe AUD prevalence remaining stable across males, females, and most subgroups. The increased prevalence underscores the importance of early detection, routine screening, timely access to evidence-based CUD treatment, and targeted strategies to counter increasing acceptance, availability, and potency of cannabis products. High prevalence of moderate-to-severe CUD among adults who use cannabis challenges the notion that cannabis has low addictive potential.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Han B, Compton WM, Hobin JA, et al. Trends in the Prevalence and Severity of Alcohol and Cannabis Use Disorders Among US Adults. JAMA Psychiatry. 2026. PMID: 42616541. doi:10.1001/jamapsychiatry.2026.2497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。